OPAD Earnings

OPAD reported its earnings on 2026-02-23, showcasing a revenue of 114.12M against an estimate of 119.12M, resulting in a -4.2% surprise. The EPS was -0.26, surpassing the expected -0.28 by 7.14%. The stock experienced a -3.7% price change on the earnings day and a -3.7% change over the next five days, reflecting market reactions to the results.

Following OPAD's earnings announcement on 2026-02-23, the stock price moved by -3.7% on the day of the release. Over the subsequent five days, it saw a -3.7% change. Historically, OPAD's stock price tends to shift by an average of 26.11% in the 10 days leading up to earnings and -5.11% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate OPAD's annual revenue to reach 200.05M, while the EPS is projected at -0.18. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates revised upward by 5.44% over the past three months, indicating analyst expectation in the company's performance.

The correlation between OPAD's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved revised upward by 5.44%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, OPAD's stock price typically moves by 26.11% in the 10 days before its earnings and -5.11% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of -0.18 and revenue of 200.05M.

The earnings call reveals mixed signals: revenue and gross margin are stable, but there's an adjusted EBITDA loss and no specific guidance for upcoming quarters, which could concern investors. The Q&A highlights reliance on AI and potential regulatory risks, yet also notes efficiency gains and strategic growth plans. Liquidity is strong, with a recent capital raise. Overall, the sentiment is balanced, with no strong positive or negative catalysts, leading to a neutral stock price prediction.